DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

计划入组 500 人 · 首次发布于 2012 年 5 月 1 日

Proteus Sustained Behavior Change Study

首次发布于 2012 年 1 月 2 日

A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

计划入组 112 人 · 首次发布于 2016 年 11 月 3 日

Xanthanine DPP-IV Inhibitors(Boehringer Ingelheim)

DPP-IV inhibitors (type 2 diabetes)

DPP-IV inhibitors (Chinese Academy of Sciences/Zhejiang University)

DPP PHARMACEUTICALS PTY LTD

Australia

Heart Hospital IV, L.P.

United States

Ligand Pharmaceuticals

United States

GLP-1 Receptor Agonists Reduce Amputation Risk and Cardiovascular Events in High-Risk Diabetes Patients

FDA Approves Zituvimet XR for Type 2 Diabetes

GLP-1 Receptor Agonists Linked to Fewer Diabetic Foot Ulcers but Higher Charcot Risk Than DPP-4 Inhibitors